Qure.ai will unveil its AI-powered lung cancer continuum at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, from May 31 to June 4.
Qure.ai will unveil its lung care continuum at the ASCO annual meeting.Qure.ai
The end-to-end care continuum is designed to support clinicians and promote developments for lung health in the pharmaceutical and medical device industries. It features AI tools that identify, measure, manage, and monitor lung health developments. Examples of its capabilities include identifying missed lung nodules from chest x-rays and supporting early lung cancer diagnosis, as well as measuring lung nodules via CT scans and tracking volumetric growth, the company said.
